{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:01:35Z","timestamp":1791284495833,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bulcan.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:32:29Z","timestamp":1697297549000},"page":"S84-S95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["Actualisation des protocoles de mobilisation et conditionnement pour la pratique des autogreffes de cellules souches h\u00e9matopo\u00ef\u00e9tiques chez les patients atteints de maladies auto-immunes\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (MATHEC-SFGM-TC)"],"prefix":"10.1016","volume":"111","author":[{"given":"Agn\u00e8s","family":"Bonnin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Terriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Beuvon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Tudesq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Puyade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Pugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Castilla","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Lansiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Cacciatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Badoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-1352","authenticated-orcid":false,"given":"Dominique","family":"Farge-Bancel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bulcan.2023.09.002_bib0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.bmt.1700727","article-title":"Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for blood and marrow transplantation (EBMT)","volume":"19","author":"Tyndall","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bulcan.2023.09.002_bib0010","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/bmt.2011.185","article-title":"Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for blood and marrow transplantation","volume":"47","author":"Snowden","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2023.09.002_bib0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.patbio.2014.05.012","article-title":"Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC","volume":"62","author":"Farge","year":"2014","journal-title":"Pathol Biol (Paris)"},{"issue":"8","key":"10.1016\/j.bulcan.2023.09.002_bib0020","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.bulcan.2023.09.002_bib0025","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.bbmt.2018.06.025","article-title":"Systemic sclerosis as an indication for autologous hematopoietic cell transplantation: position statement from the American Society for blood and marrow transplantation","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1S","key":"10.1016\/j.bulcan.2023.09.002_bib0030","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/j.bulcan.2018.11.002","volume":"106","author":"Zephir","year":"2019","journal-title":"Bull Cancer (Paris)"},{"issue":"2","key":"10.1016\/j.bulcan.2023.09.002_bib0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jamaneurol.2020.4025","article-title":"Autologous hematopoietic stem cell transplant in multiple sclerosis: recommendations of the National Multiple Sclerosis Society","volume":"78","author":"Miller","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.bulcan.2023.09.002_bib0040","doi-asserted-by":"crossref","first-page":"556141","DOI":"10.3389\/fneur.2020.556141","volume":"11","author":"Roberts","year":"2020","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.bulcan.2023.09.002_bib0045","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","article-title":"Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022","volume":"57","author":"Snowden","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2023.09.002_bib0050","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/rheumatology\/keab877","article-title":"Long-term follow-up after lymphodepleting autologous hematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus","volume":"61","author":"Goklemez","year":"2022","journal-title":"Rheumatol Oxf Engl"},{"issue":"2","key":"10.1016\/j.bulcan.2023.09.002_bib0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/ard.2006.056630","volume":"66","author":"Daikeler","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.bulcan.2023.09.002_bib0060","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/s41409-019-0763-2","article-title":"Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry","volume":"55","author":"Alexander","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.bulcan.2023.09.002_bib0065","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/s41409-020-0907-4","volume":"55","author":"Laurent","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2023.09.002_bib0070","doi-asserted-by":"crossref","first-page":"638709","DOI":"10.3389\/fimmu.2021.638709","article-title":"Autologous hematopoietic stem cell transplantation for Beh\u00e7et's disease: a retrospective survey of patients treated in Europe, on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation","volume":"12","author":"Puyade","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.09.002_bib0075","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/gutjnl-2015-309836","article-title":"Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease","volume":"65","author":"Jauregui-Amezaga","year":"2016","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.bulcan.2023.09.002_bib0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(17)30056-0","article-title":"Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial","volume":"2","author":"Lindsay","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12S","key":"10.1016\/j.bulcan.2023.09.002_bib0085","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1016\/j.bulcan.2020.08.009","article-title":"Crohn's disease and autologous hemapoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"107","author":"Puyade","year":"2020","journal-title":"Bull Cancer (Paris)"},{"issue":"11","key":"10.1016\/j.bulcan.2023.09.002_bib0090","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1007\/s00415-020-10010-6","article-title":"Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"267","author":"Burt","year":"2020","journal-title":"J Neurol"},{"issue":"1S","key":"10.1016\/j.bulcan.2023.09.002_bib0095","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.bulcan.2019.11.002","article-title":"Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"107","author":"Puyade","year":"2020","journal-title":"Bull Cancer (Paris)"},{"issue":"4","key":"10.1016\/j.bulcan.2023.09.002_bib0100","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1007\/s00415-021-10452-6","article-title":"Hematopoietic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: French experience about four patients, under the behalf of French society for bone marrow transplantation","volume":"268","author":"Urbain","year":"2021","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.09.002_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1352458514541978","article-title":"Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party","volume":"21","author":"Greco","year":"2015","journal-title":"Mult Scler"},{"issue":"18","key":"10.1016\/j.bulcan.2023.09.002_bib0110","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1212\/WNL.0000000000008394","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica","volume":"93","author":"Burt","year":"2019","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.bulcan.2023.09.002_bib0115","doi-asserted-by":"crossref","first-page":"E5304","DOI":"10.3390\/ijms21155304","article-title":"Hematopoietic stem cell transplantation in neuromyelitis optica-spectrum disorders (NMO-SD): State-of-the-Art and future perspectives","volume":"21","author":"Ceglie","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"12S","key":"10.1016\/j.bulcan.2023.09.002_bib0120","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.bulcan.2017.06.019","article-title":"Indications and follow-up for autologous hematopoietic stem cell transplantation in autoimmune and autoinflammatory diseases: guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"104","author":"Pugnet","year":"2017","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2023.09.002_bib0125","unstructured":"HAS. [Internet] Protocole national de diagnostic et de soins-greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques dans les maladies auto-immunes, 2022. https:\/\/www.has-sante.fr\/jcms\/p_3374064\/fr\/greffe-de-cellules-souches-hematopoietiques-dans-les-maladies-auto-immunes."},{"issue":"1","key":"10.1016\/j.bulcan.2023.09.002_bib0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41409-020-0978-2","article-title":"Cardiac safe hematopoietic stem cell transplantation for systemic sclerosis with poor cardiac function: a pilot safety study that decreases neutropenic interval to 5\u00a0days","volume":"56","author":"Burt","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"11S","key":"10.1016\/j.bulcan.2023.09.002_bib0135","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"How we harmonize HSCT clinical practices among the SFGM-TC centers","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2023.09.002_bib0140","doi-asserted-by":"crossref","first-page":"104065","DOI":"10.1016\/j.lpm.2021.104065","article-title":"Autologous stem cell transplantation in scleroderma","volume":"50","author":"Farge","year":"2021","journal-title":"Presse Med"},{"issue":"11","key":"10.1016\/j.bulcan.2023.09.002_bib0145","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2023.09.002_bib0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41409-019-0684-0","volume":"55","author":"Sharrack","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2023.09.002_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1703081","article-title":"Collection of hematopoietic stem cells from patients with autoimmune diseases","volume":"28","author":"Burt","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2023.09.002_bib0160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0192623312467400","article-title":"Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans","volume":"41","author":"Everds","year":"2013","journal-title":"Toxicol Pathol"},{"issue":"12","key":"10.1016\/j.bulcan.2023.09.002_bib0165","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1038\/bmt.2017.188","article-title":"Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening","volume":"52","author":"Martin","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2023.09.002_bib0170","unstructured":"HAS. [Internet] Protocole national de diagnostic et de soins-scl\u00e9rodermie syst\u00e9mique, 2022. https:\/\/www.has-sante.fr\/jcms\/c_717292\/fr\/sclerodermie-systemique."},{"key":"10.1016\/j.bulcan.2023.09.002_bib0175","unstructured":"SFSEP. [Internet] Recommandations de la Soci\u00e9t\u00e9 francophone de la scl\u00e9rose en plaques \u00ab\u00a0infections urinaires et scl\u00e9rose en plaques\u00a0\u00bb. https:\/\/sfsep.org\/wp-content\/uploads\/2020\/07\/SFSEP-Recommandations_IU_et_SEP.pdf."},{"issue":"12","key":"10.1016\/j.bulcan.2023.09.002_bib0180","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123003739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455123003739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:38:19Z","timestamp":1757792299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455123003739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0007455123003739"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.09.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualisation des protocoles de mobilisation et conditionnement pour la pratique des autogreffes de cellules souches h\u00e9matopo\u00ef\u00e9tiques chez les patients atteints de maladies auto-immunes\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (MATHEC-SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}